| Highly pure phentolamine mesylate and methods for making same |
2022-12-30 |
2023-5-11 |
|
| Methods and compositions for treatment of mydriasis |
2022-7-29 |
2023-2-09 |
|
| Highly pure phentolamine mesylate and methods for making same |
2022-5-18 |
2023-11-02 |
|
| Highly pure phentolamine mesylate and methods for making same |
2022-5-18 |
2022-11-24 |
|
| Methods and compositions for treatment of diabetic retinopathy and related … |
2022-4-29 |
2023-11-16 |
|
| Methods and compositions for treatment of diabetic retinopathy and related … |
2022-4-29 |
2022-11-03 |
|
| Methods and compositions for treatment of diabetic retinopathy and related … |
2022-4-29 |
2022-11-03 |
|
| Methods and compositions for treating mydriasis, glaucoma, and other ocular … |
2022-4-22 |
2023-11-16 |
|
| Methods and compositions for treating mydriasis, glaucoma, and other ocular … |
2022-4-22 |
2022-10-27 |
|
| Aqueous ophthalmic solutions of phentolamine and medical uses thereof |
2021-8-13 |
2022-6-09 |
|
| Methods and compositions for daily ophthalmic administration of phentolamine to … |
2021-4-13 |
2021-11-04 |
|
| Methods and compositions for treatment of glaucoma and related conditions |
2019-10-15 |
2020-4-23 |
|
| Quinoxalinyl-piperazinamide methods of use |
2018-4-06 |
2020-2-25 |
2020-2-25 |
| Fluorocyclopentenylcytosine methods of use |
2017-8-22 |
2018-1-25 |
|
| Nanoparticulate compositions and formulations of piperazine compounds |
2017-7-26 |
2018-8-21 |
2018-8-21 |
| Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3- … |
2016-12-15 |
2017-6-08 |
|
| Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds |
2015-10-21 |
2016-5-19 |
|
| 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine … |
2012-10-26 |
2013-12-03 |
2013-12-03 |
| 5, 6, or 7-substituted -3-(hetero) arylisoquinolinamine derivatives and … |
2011-10-07 |
2012-11-20 |
2012-11-20 |
| Polymeric systems for the delivery of anticancer drugs |
2010-10-13 |
2014-9-30 |
2014-9-30 |
| Quinazoline Derivatives and Therapeutic Use Thereof |
2008-6-16 |
2009-1-29 |
|
| Nucleoside derivatives and therapeutic uses therof |
2005-4-01 |
2005-10-06 |
|
| Antisense oligonucleotides that inhibit expression of HIF-1 |
2004-1-28 |
2007-4-17 |
2007-4-17 |
| Use of antisense oligonucleotides to inhibit the expression of human Akt-1 |
2003-8-13 |
2004-12-30 |
|
| Ophthalmic formulation which modulates dilation |
2002-6-07 |
2003-2-04 |
2003-2-04 |
| Night vision composition |
2000-9-29 |
2004-5-04 |
2004-5-04 |
| Mesylate de phentolamine de haute purete et ses methodes de production |
2022-5-18 |
2022-11-24 |
|
| Methodes et compositions pour le traitement de la retinopathie diabetique et … |
2022-4-29 |
2022-11-03 |
|